Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Jul;34(7):1672–1676. doi: 10.1128/jcm.34.7.1672-1676.1996

Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest.

A Wanger 1, K Mills 1
PMCID: PMC229092  PMID: 8784567

Abstract

Etest (AB BIODISK, Solna, Sweden) is a precise MIC method and the practical method of choice for the susceptibility testing of many fastidious organisms, including rapidly growing mycobacteria. Methods recommended by the National Committee for Clinical Laboratory Standards for the susceptibility testing of Mycobacterium tuberculosis include the Bactec (Becton Dickinson, Sparks, Md.) broth and agar proportion methods. A comparison of Etest with the Bactec broth method for testing the susceptibility of M. tuberculosis to four first-line antituberculous agents demonstrated equivalent interpretive results for 100% of the isolates tested. Agreements with agar proportion MICs, within +/-2 log2 dilutions, were 90, 93, 100, and 94% for ethambutol, isoniazid, rifampin, and streptomycin, respectively. Etest MICs were easily read within 5 to 10 days of inoculation. Preparation of the inoculum with a turbidity equivalent to a McFarland 3.0 standard prepared from growth on an agar surface and with a broth with a Bactec growth index of > 999 yielded equivalent results. Clinical isolates for which the MICs were reproducible were also identified as possible quality control strains. The Etest method appears to be an alternative method for testing the susceptibility of M. tuberculosis isolates to the four most commonly used therapeutic agents.

Full Text

The Full Text of this article is available as a PDF (510.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biehle J. R., Cavalieri S. J., Saubolle M. A., Getsinger L. J. Evaluation of Etest for susceptibility testing of rapidly growing mycobacteria. J Clin Microbiol. 1995 Jul;33(7):1760–1764. doi: 10.1128/jcm.33.7.1760-1764.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bloom B. R., Murray C. J. Tuberculosis: commentary on a reemergent killer. Science. 1992 Aug 21;257(5073):1055–1064. doi: 10.1126/science.257.5073.1055. [DOI] [PubMed] [Google Scholar]
  3. Heifets L. Qualitative and quantitative drug-susceptibility tests in mycobacteriology. Am Rev Respir Dis. 1988 May;137(5):1217–1222. doi: 10.1164/ajrccm/137.5.1217. [DOI] [PubMed] [Google Scholar]
  4. Hoffner S. E., Klintz L., Olsson-Liljequist B., Bolmström A. Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum. J Clin Microbiol. 1994 Aug;32(8):1846–1849. doi: 10.1128/jcm.32.8.1846-1849.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Inderlied C. B. Antimycobacterial susceptibility testing: present practices and future trends. Eur J Clin Microbiol Infect Dis. 1994 Nov;13(11):980–993. doi: 10.1007/BF02111499. [DOI] [PubMed] [Google Scholar]
  6. Iseman M. D. Treatment of multidrug-resistant tuberculosis. N Engl J Med. 1993 Sep 9;329(11):784–791. doi: 10.1056/NEJM199309093291108. [DOI] [PubMed] [Google Scholar]
  7. Jacobs R. F. Multiple-drug-resistant tuberculosis. Clin Infect Dis. 1994 Jul;19(1):1–10. doi: 10.1093/clinids/19.1.1. [DOI] [PubMed] [Google Scholar]
  8. Koontz F. P., Erwin M. E., Barrett M. S., Jones R. N. Etest for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates. Diagn Microbiol Infect Dis. 1994 Jul;19(3):183–186. doi: 10.1016/0732-8893(94)90065-5. [DOI] [PubMed] [Google Scholar]
  9. McKenna M. T., McCray E., Onorato I. The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med. 1995 Apr 20;332(16):1071–1076. doi: 10.1056/NEJM199504203321606. [DOI] [PubMed] [Google Scholar]
  10. Pfaller M. A. Application of new technology to the detection, identification, and antimicrobial susceptibility testing of mycobacteria. Am J Clin Pathol. 1994 Mar;101(3):329–337. doi: 10.1093/ajcp/101.3.329. [DOI] [PubMed] [Google Scholar]
  11. Salfinger M., Pfyffer G. E. The new diagnostic mycobacteriology laboratory. Eur J Clin Microbiol Infect Dis. 1994 Nov;13(11):961–979. doi: 10.1007/BF02111498. [DOI] [PubMed] [Google Scholar]
  12. Tenover F. C., Crawford J. T., Huebner R. E., Geiter L. J., Horsburgh C. R., Jr, Good R. C. The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol. 1993 Apr;31(4):767–770. doi: 10.1128/jcm.31.4.767-770.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wanger A., Mills K. Etest for susceptibility testing of Mycobacterium tuberculosis and Mycobacterium avium-intracellulare. Diagn Microbiol Infect Dis. 1994 Jul;19(3):179–181. doi: 10.1016/0732-8893(94)90064-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES